Tags

Type your tag names separated by a space and hit enter

A fetal mouse model of ventricular non-compaction using retinoic acid.

Abstract

OBJECTIVE

To develop a fetal mouse model of non-compaction of ventricular myocardium (NVM) using All-trans retinoic acid (ATRA).

METHODS

Pregnant mice were divided into blank control group, dimethyl sulfoxide (DMSO) control group and ATRA group. The pregnant mice at 8.5 days after pregnancy were given 70 mg/kg ATRA in DMSO to induce fetal mouse model of NVM in ATRA group. All the hearts were acquired and sliced in short axis from the neonatal mice sacrificed after delivery. Pathological changes were visualized under 40- and 100-fold magnification with Hematoxylin-eosin (HE) staining at different ventricular levels. The criteria for pathological diagnosis of classical NVM were: prominent trabeculations on the endocardial surface and deep intertrabecular recesses communicating with the ventricular cavity and the thickness ratio of non-compacted layer (N) to compact myocardium layer (C) N/C > 1.4. Analysis of variance (ANOVA) and least significant difference (LSD) were used to analyze the differences of three groups, with P < 0.05 considered as significant.

RESULTS

The typical characteristics of NVM histopathological findings of ATRA fetal mouse were confirmed: compared to the hearts of blank control group (n = 20) and DMSO control group (n = 15), all the hearts of ATRA group (n = 17) showed the obviously thinner compacted layer and the much thicker non-compacted layer. The N/C ratio of left ventricles (LVs) in ATRA group was 2.735 ± 1.634, higher than those in DMSO control group 0.178 ± 0.119 and blank control group 0.195 ± 0.118 with significant difference (F = 32.550, P <0. 0001); N/C ratios of right ventricles (RVs) in the ATRA group were (6.068 ± 4.394), higher than those in the DMSO control group 0.459 ± 0.24 and in the blank control group 0.248 ± 0.182 with significant difference (F = 20.069, P <0.0001). LSD of LVs and RVs showed a significant difference between ATRA and blank control group (P < 0.0001), and between ATRA and DMSO control group (P < 0.0001). LSD showed no significant difference in two control groups of LVs (P = 0.963) and of RVs (P = 0.848) .

CONCLUSION

Excess ATRA could be used to induce NVM of fetal mice heart. This animal model might provide a platform for fundamental research of NVM pathogenesis and potential targeting treatment.

Links

  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    School of Medicine, University of Electronic Science and Technology of China, Chengdu 610054, China.

    ,

    School of Medicine, University of Electronic Science and Technology of China, Chengdu 610054, China.

    School of Medicine, University of Electronic Science and Technology of China, Chengdu 610054, China; Sichuan Provincial Key Laboratory for Ultrasound in Cardiac Electrophysiology and Biomechanics, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China. Electronic address: yinlixue_cardiac@163.com.

    Source

    Pathology, research and practice : 2019 Jun 10 pg 152496

    Pub Type(s)

    Journal Article

    Language

    eng

    PubMed ID

    31204178

    Citation

    Cao, Fei, et al. "A Fetal Mouse Model of Ventricular Non-compaction Using Retinoic Acid." Pathology, Research and Practice, 2019, p. 152496.
    Cao F, Yang Z, Yin L. A fetal mouse model of ventricular non-compaction using retinoic acid. Pathol Res Pract. 2019.
    Cao, F., Yang, Z., & Yin, L. (2019). A fetal mouse model of ventricular non-compaction using retinoic acid. Pathology, Research and Practice, p. 152496. doi:10.1016/j.prp.2019.152496.
    Cao F, Yang Z, Yin L. A Fetal Mouse Model of Ventricular Non-compaction Using Retinoic Acid. Pathol Res Pract. 2019 Jun 10;152496. PubMed PMID: 31204178.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - A fetal mouse model of ventricular non-compaction using retinoic acid. AU - Cao,Fei, AU - Yang,Zhenglin, AU - Yin,Lixue, Y1 - 2019/06/10/ PY - 2019/04/03/received PY - 2019/05/26/revised PY - 2019/06/08/accepted PY - 2019/6/18/entrez KW - Animal model KW - Non-Compaction of ventricular myocardium (NVM) KW - Retinoic acid (RA) SP - 152496 EP - 152496 JF - Pathology, research and practice JO - Pathol. Res. Pract. N2 - OBJECTIVE: To develop a fetal mouse model of non-compaction of ventricular myocardium (NVM) using All-trans retinoic acid (ATRA). METHODS: Pregnant mice were divided into blank control group, dimethyl sulfoxide (DMSO) control group and ATRA group. The pregnant mice at 8.5 days after pregnancy were given 70 mg/kg ATRA in DMSO to induce fetal mouse model of NVM in ATRA group. All the hearts were acquired and sliced in short axis from the neonatal mice sacrificed after delivery. Pathological changes were visualized under 40- and 100-fold magnification with Hematoxylin-eosin (HE) staining at different ventricular levels. The criteria for pathological diagnosis of classical NVM were: prominent trabeculations on the endocardial surface and deep intertrabecular recesses communicating with the ventricular cavity and the thickness ratio of non-compacted layer (N) to compact myocardium layer (C) N/C > 1.4. Analysis of variance (ANOVA) and least significant difference (LSD) were used to analyze the differences of three groups, with P < 0.05 considered as significant. RESULTS: The typical characteristics of NVM histopathological findings of ATRA fetal mouse were confirmed: compared to the hearts of blank control group (n = 20) and DMSO control group (n = 15), all the hearts of ATRA group (n = 17) showed the obviously thinner compacted layer and the much thicker non-compacted layer. The N/C ratio of left ventricles (LVs) in ATRA group was 2.735 ± 1.634, higher than those in DMSO control group 0.178 ± 0.119 and blank control group 0.195 ± 0.118 with significant difference (F = 32.550, P <0. 0001); N/C ratios of right ventricles (RVs) in the ATRA group were (6.068 ± 4.394), higher than those in the DMSO control group 0.459 ± 0.24 and in the blank control group 0.248 ± 0.182 with significant difference (F = 20.069, P <0.0001). LSD of LVs and RVs showed a significant difference between ATRA and blank control group (P < 0.0001), and between ATRA and DMSO control group (P < 0.0001). LSD showed no significant difference in two control groups of LVs (P = 0.963) and of RVs (P = 0.848) . CONCLUSION: Excess ATRA could be used to induce NVM of fetal mice heart. This animal model might provide a platform for fundamental research of NVM pathogenesis and potential targeting treatment. SN - 1618-0631 UR - https://www.unboundmedicine.com/medline/citation/31204178/A_fetal_mouse_model_of_ventricular_non-compaction_using_retinoic_acid L2 - https://linkinghub.elsevier.com/retrieve/pii/S0344-0338(19)30604-1 DB - PRIME DP - Unbound Medicine ER -